The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...

With threats of tariffs hanging over the pharmaceutical industry, Switzerland’s Roche announced on Tuesday that it will ...

Roche's decision to invest heavily in the US – along with Novartis' announcement, has come hard on the heels of European ...

Roche has pledged to build a giant weight-loss drug factory in the US. The plans form part of a $50bn (£37bn) pledge aimed at ...

Bayer AG (Leverkusen, Germany) announced the grand opening of its new 70,000 square foot expansion at its Myerstown, ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

In addition, the company is planning to build a new plant in Indiana for continuous glucose monitoring devices and a state-of-the-art gene therapy manufacturing facility in Pennsylvania ...

Once the new and expanded manufacturing capacities are operational, Roche aims to export more medicines from the US than it ...

A Houston-based compounding pharmacy that was recently roped into Eli Lilly’s fight against knockoff GLP-1s has landed in the FDA’s crosshairs for the second time in less than a year. | The FDA has ...

Pharma companies have in recent months set ... so far been exempted from such levies–and seeks to revive domestic manufacturing.

But pharma companies could potentially avoid ... Planned new sites include a gene therapy manufacturing facility in Pennsylvania, a glucose monitor manufacturing site in Indiana, and a new R ...

Investments will create more than 12,000 new jobs: 1,000 at Roche and more than 11,000 in support of new US manufacturing ...